Skip to content

mouse anti-Helicobacter pylori monoclonal antibody (HP1811) 5858

$231.00

Antibody summary

  • Mouse monoclonal to Helicobacter pylori
  • Suitable for: ELISA,WB
  • Isotype: IgG
  • 200 µg
SKU: 5858parent Category: Tags: , ,
Weight1 lbs
Dimensions9 × 5 × 2 in
host

mouse

isotype

IgG

clonality

monoclonal

concentration

1 mg/mL

applications

ICC/IF, WB

reactivity

Helicobacter pylori

available sizes

200 µg

mouse anti-Helicobacter pylori monoclonal antibody (HP1811) 5858

antibody
Tested applications
WB,ELISA
Recommended dilutions
ELISA, Immunoblotting

End users should determine optimal antibody concentrations relative to their preparations of H. pylori.
Immunogen
Recombinant fragments of H. pylori CagA protein
Size and concentration
200µg and lot specific
Form
liquid
Storage Instructions
Store product at 4°C.
Storage buffer
PBS, pH 7.4, 0.09% NaN3.
Purity
protein affinty purification
Clonality
monoclonal
Isotype
IgG3
Compatible secondaries
goat anti-mouse IgG, H&L chain specific, peroxidase conjugated polyclonal antibody 5486
goat anti-mouse IgG, H&L chain specific, biotin conjugated, Conjugate polyclonal antibody 2685
goat anti-mouse IgG, H&L chain specific, FITC conjugated polyclonal antibody 7854
goat anti-mouse IgG, H&L chain specific, peroxidase conjugated polyclonal antibody, crossabsorbed 1706
goat anti-mouse IgG, H&L chain specific, biotin conjugated polyclonal antibody, crossabsorbed 1716
goat anti-mouse IgG, H&L chain specific, FITC conjugated polyclonal antibody, crossabsorbed 1721
Isotype control
Mouse monocolonal IgG3 - Isotype Control
target relevance
Structure
Helicobacter pylori, previously known as Campylobacter pylori, is a gram-negative, flagellated, helical bacterium. Mutants can have a rod or curved rod shape, and these are less effective. Its helical body (from which the genus name, Helicobacter, derives) is thought to have evolved in order to penetrate the mucous lining of the stomach, helped by its flagella, and thereby establish infection. The bacterium was first identified as the causal agent of gastric ulcers in 1983 by the Australian doctors Barry Marshall and Robin Warren.
Biotechnology
In the diagnosis of H. pylori infections, a distinction is made between non-invasive and invasive methods. Invasive procedures contain histology, urease rapid test and microbiological techniques such as cultivation and PCR. The C13-breath test, the Helicobacter pylori antigen detection in stool samples and serological antibody detection based on ELISA or immunoblot belong to the group of non-invasive methods. The detection of serum antibodies can be used for therapy control after eradication therapy

Data

No results found

Publications

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.




pmidtitleauthorscitation

Protocols

relevant to this product
Western blot
IHC
ICC

Documents

#
No results found

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.